Endoscopy 2007; 39(9): 779-783
DOI: 10.1055/s-2007-966761
Original article

© Georg Thieme Verlag KG Stuttgart · New York

Clinical outcome after endoscopic mucosal resection for esophageal squamous cell carcinoma invading the muscularis mucosae - a multicenter retrospective cohort study

C.  Katada1 , M.  Muto1 , K.  Momma2 , M.  Arima3 , H.  Tajiri4 , C.  Kanamaru4 , H.  Ooyanagi5 , H.  Endo6 , T.  Michida7 , N.  Hasuike8 , I.  Oda8 , T.  Fujii8 , D.  Saito8
  • 1Division of Digestive Endoscopy and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
  • 2Department of Endoscopy, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
  • 3Department of Gastroenterology, Saitama Cancer Center Hospital, Saitama, Japan
  • 4Department of Endoscopy, The Jikei University School of Medicine, Tokyo, Japan
  • 5Department of Diagnostic Imaging, Division of Endoscopy, Tochigi Cancer Center Hospital, Utsunomiya, Japan
  • 6Department of Internal Medicine, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan
  • 7Department of Gastroenterology, Osaka National Hospital, Osaka, Japan
  • 8Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan
Further Information

Publication History

submitted 22 May 2007

accepted after revision 13 June 2007

Publication Date:
17 August 2007 (online)

Background and study aims: Endoscopic mucosal resection (EMR) is now commonly indicated for esophageal squamous cell carcinoma (ESCC) within the lamina propria mucosa. However, EMR for ESCC that has invaded the muscularis mucosa is controversial because the risk of lymph node metastasis is not negligible. We conducted a multicenter retrospective cohort study to investigate the incidence of lymph node metastasis and survival after EMR for ESCC invading the muscularis mucosa.

Patients and methods: A total of 104 patients with 111 lesions invading the muscularis mucosa, were retrospectively studied at eight institutes. No patients exhibited evidence of metastasis of lymph nodes or distant organs prior to EMR. Overall and cause-specific survival rates were calculated from the date of EMR to the date of death or the most recent follow-up visit. Survival curves were plotted according to the Kaplan-Meier method.

Results: In total, 86 patients (82.7 %) who did not receive further treatment such as chemotherapy, irradiation therapy, chemoradiotherapy, or esophagectomy after EMR were followed up. Only two patients (1.9 %) developed lymph node metastasis after EMR. With a median follow-up period of 43 months (range, 8 - 134 months), overall and cause-specific survival rates at 5 years after EMR were 79.5 % and 95.0 %, respectively.

Conclusions: EMR for ESCC that invades the muscularis mucosa has curative potential as a minimally invasive treatment option.

References

  • 1 Yoshinaka H, Shimazu H, Fukumoto T. et al . Superficial esophageal carcinoma: a clinicopathological review of 59 cases.  Am J Gastroenterol. 1991;  86 1413-1418
  • 2 Endo M. Endoscopic resection as local treatment of mucosal cancer of the esophagus.  Endoscopy. 1993;  25 672-674
  • 3 Nishimaki T, Tanaka O, Suzuki T. et al . Tumor spread in superficial esophageal cancer: histopathologic basis for rational surgical treatment.  World J Surg. 1993;  17 766-771
  • 4 Nabeya K, Hanaoka T, Li S, Nyumura T. What is the ideal treatment for early esophageal cancer?.  Endoscopy. 1993;  25 670-671
  • 5 Nagawa H, Kaizaki S, Seto Y. et al . The relationship of macroscopic shape of superficial esophageal carcinoma to depth of invasion and regional lymph node metastasis.  Cancer. 1995;  75 1061-1064
  • 6 Matsubara T, Ueda M, Abe T. et al . Unique distribution patterns of metastatic lymph nodes in patients with superficial carcinoma of the thoracic oesophagus.  Br J Surg. 1999;  86 669-673
  • 7 Tachibana M, Yoshimura H, Kinugasa S. et al . Clinicopathological features of superficial squamous cell carcinoma of the esophagus.  Am J Surg. 1997;  174 49-53
  • 8 Noguchi H, Naomoto Y, Kondo H. et al . Evaluation of endoscopic mucosal resection for superficial esophageal carcinoma.  Surg Laparosc Endosc Percutan Tech. 2000;  10 343-350
  • 9 Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of the responses to a questionnaire on superficial cancer of the esophagus in Japan.  Surgery. 1998;  123 432-439
  • 10 Endo M, Yoshino K, Kawano T. et al . Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus.  Dis Esoph. 2000;  13 125-129
  • 11 Fujita H, Sueyoshi S, Yamana H. et al . Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy.  World J Surg. 2001;  25 424-431
  • 12 Buskens C J, Westerterp M, Lagarde S M. et al . Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features.  Gastrointest Endosc. 2004;  60 703-710
  • 13 Araki K, Ohno S, Egashira A. et al . Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis.  Cancer. 2002;  94 570-575
  • 14 Momma K, Sakaki N, Yoshida M. Endoscopic mucosectomy for precise evaluation and treatment of esophageal intraepithelial cancer [in Japanese with English abstract].  Endoscopia Digestiva. 1990;  2 501-506
  • 15 Makuuchi H. Endoscopic mucosal resection for early esophageal cancer [editorial].  Dig Endosc. 1996;  8 175-179
  • 16 Makuuchi H. Endoscopic mucosal resection for mucosal cancer in the esophagus.  Gastrointest Endosc Clin N Am. 2001;  11 445-458
  • 17 Suzuki H. Endoscopic mucosal resection using ligating device for early gastric cancer.  Gastrointest Endosc Clin N Am. 2001;  11 511-518
  • 18 Inoue H. Endoscopic mucosal resection for esophageal and gastric mucosal cancers.  Can J Gastroenterol. 1998;  12 355-359
  • 19 Japanese Society for Esophageal Disease .Guidelines for clinical and pathologic studies on carcinoma of the esophagus (in Japanese). 9th edn.  Tokyo; Kanehara Shuppan 1999
  • 20 Lightdale C J, Lambert R. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon.  Gastrointest Endosc. 2003;  58 (6 Suppl) S3-S43
  • 21 Lambert R. Diagnosis of esophagogastric tumors.  Endoscopy. 2004;  36 110-119
  • 22 Lambert R, Hainaut P, Parkin D M. Premalignant lesions of the esophagogastric mucosa.  Semin Oncol. 2004;  31 498-512
  • 23 Isono K, Ochiai T. Recent advances of treatments of cancer of the esophagus.  Ann Cancer Res Ther. 1992;  1 9-16
  • 24 Oyama T, Miyata Y, Shimatani S. et al . Lymph nodal metastasis of m3, sm1 esophageal cancer (in Japanese with English abstract).  I to Cho. 2002;  37 71-74
  • 25 Shimizu Y, Tsukagoshi H, Fujita M. et al . Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper.  Gastrointest Endosc. 2002;  56 387-390

M. Muto, MD

Division of Digestive Endoscopy and Gastrointestinal Oncology

National Cancer Center Hospital East

6-5-1 Kashiwanoha

Kashiwa 277-8577

Japan

Fax: +81-4-71314724

Email: mmuto@east.ncc.go.jp

    >